Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort studyIsabel Brosius, Placide Mbala‐Kingebeni, Espoir Bwenge Malembaka et al.|The Lancet|2025Cited by 67
Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trialChristophe Van Dijck, Chris Kenyon, Elke Paeleman et al.|The Lancet Infectious Diseases|2021Cited by 45
Antimalarial artesunate–mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trialEmmanuel Bottieau, Katja Polman, Christophe Burm et al.|Nature Medicine|2024Cited by 16
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trialClémentine Roucher, Emmanuel Bottieau, Christophe Burm et al.|BMJ Open|2021Cited by 7